– Debut on Nasdaq follows completion of the company’s business combination with Oaktree Acquisition Corp. II, which included a fully committed and upsized $175 million PIPE
Tag: Robert Wessman
Alvotech and STADA Pave Way resolve European Patent Dispute With AbbVie and launch UKYNDRA®(AVT02)
REYKJAVIK, Iceland & BAD VILBEL, Germany, 06.04.2022 – Alvotech Holdings S.A. (“Alvotech”), a global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines
Actavis announces senior appointments
Following Robert Wessman’s departure as CEO, a number of changes in senior management have taken place at the generic pharmaceuticals manufacturer. Actavis Group, the international
Actavis CEO to present at UBS pharmaceuticals conference
Robert Wessman will speak on “The strategy and competitiveness of Actavis in a fiercely competitive environment” in London on Wednesday. Actavis generic pharmaceuticals have announced
